Consequences of higher IGFBP-5 expression levels for metabolic complications have not been analyzed in detail yet; however, these findings suggest a possible involvement of IGFBP-5 in the development of metabolic disorders in abdominal adipose tissue. This evidence concerns the gene IGFBP5 and metabolic disease.